The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

Potential Cardio-protective Role of Dapagliflozin in Post Myocardial Infarction Patients

ASSESSMENT OF GENITAL AND URINARY TRACT INFECTIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN

Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients

Predictors of mortality and poor renal outcomes in adults with diabetic ketoacidosis

Dapagliflozin Ameliorates Glycemic State, Lipid Profile and Renal Functions in Type 2 Diabetic Rats

The Role of Dapagliflozin in Reducing Anthracycline-Induced Cardiotoxicity in Type 2 Diabetes Mellitus Patients with Breast Cancer

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats

Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane

Impact of Diabetes on the Incidence of Contrast-Induced Nephropathy